𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Expression and function of the murine CD95/FasR/APO-1 receptor in relation to B cell ontogeny

✍ Scribed by Karen B. Onel; Carolyn L. Tucek-Szabo; Dalit Ashany; Elizabeth Lacy; Janko Nikolic-Zugic; Keith B. Elkon


Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
897 KB
Volume
25
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Mice defective in Fas‐mediated apoptosis (lpr phenotype) have an intrinsic B cell abnormality that predisposes them to autoantibody production. To investigate potential roles for the Fas receptor (FasR) in B cell tolerance, FasR expression and function were evaluated at different stages of B cell development. FasR expression was very low or absent on pro‐ and pre‐B cells, but was detected in early B cell lines and was up‐regulated following IFN‐γ‐induced maturation of the pre‐B cell line 70‐Z. Whereas FasR expression was very low in resting mature sIgM^+^ B cells, expression was markedly increased following mitogen activation and was also elevated in two mature sIgG^+^ lymphoma lines. FasR expression correlated strongly with the ability of B cells to undergo Fas‐mediated apoptosis. In addition, although Fas did not appear to play a direct role in apoptosis mediated by cross‐linking of sIg with anti‐IgM, anti‐FasR and sublethal concentrations of anti‐Ig were additive in the induction of apoptosis in the early B cell line WEHI 231. These findings suggest that the Fas pathway is not involved in the elimination of pro‐ and pre‐B cells, but are compatible with an ancillary role for FasR in the elimination of early B cells and elimination of mature B cells following activation.


📜 SIMILAR VOLUMES


Regulation of CD95 (APO-1/ FAS) ligand a
✍ Cordula Moers; Ulrich Warskulat; Markus Müschen; Jos Even; Dieter Niederacher; R 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 337 KB 👁 2 views

CD95 (Apo-1/Fas) ligand (CD95L) expression has been observed in various malignancies. In human primary cell lines from a squamous cell carcinoma (SCC) of the vulva, the effect of cisplatin (CDDP) and IFN␥ on the expression of CD95L and its 2 receptor isoforms, CD95 transmembrane (CD95tm) and CD95 so

Regulation of CD95 (APO-1/Fas) receptor
✍ Markus Müschen; Ulrich Warskulat; Patrice Douillard; Emmanuelle Gilbert; Dieter 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB

The effect of lipopolysaccharide (LPS) on the expression of CD95 (APO-1/Fas) receptor and ligand (CD95L) was studied in primary cultures of rat liver Kupffer cells (KCs), sinusoidal endothelial cells (SECs), and parenchymal cells (PCs) at the messenger RNA (mRNA) level and by means of immunocytochem

Expression of APO-1 (CD95), a member of
✍ Peter Möller; Karin Koretz; Frank Leithäuser; Silke Brüderlein; Christof Henne; 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 878 KB

APO-I is a 48-kDa cell-membrane protein identical to the Far antigen now designated CD95. It is a member of the NGF/TNF receptor superfamily. Anti-APO-I monoclonal antibody induces apoptosis in a variety of cell types expressing this antigen. We immunohistochemically investigated APO-I expression in

Roles of CXC chemokines and macrophages
✍ Motomu Shimizu; Takayuki Yoshimoto; Mayumi Sato; Junji Morimoto; Akio Matsuzawa; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 936 KB

## Abstract The role of CD95 ligand (FasL/Apo‐1L)‐expressing tumors in immunosuppression or immunopotentiation is controversial. CD95L‐transfected tumors induce immunopotentiation after vigorous neutrophil infiltration. Thus, the induction of neutrophil infiltration by CD95L seems to play an import